Skip to content

Functionele beeldvorming bij kanker van de dikke darm of endeldarm.

Mutli-modality imaging in the prediction of response to systemic treatment in colorectal cancer.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON24654
Enrollment
60
Registered
2009-04-17
Start date
2009-04-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

colorectal cancer

Interventions

1. MRI-scan
2. FDG-PET-scan.

Sponsors

UMC St Radboud, medical oncology
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Histological proven colorectal cancer with livermetastasis; 2. First line fluoropyrimidine-based treatment; 3. Measurable livermetastasis; 4. Age minimal 18 years; 5. Written informed consent.

Exclusion criteria

Exclusion criteria: 1. Prior chemotherapy within 6 months before start of the study; 2. Contra-indication for MRI and or PEt-examinations; 3. Karnofsky Performance Status =/< 70; 4. Diffuse livermetastases.

Design outcomes

Primary

MeasureTime frame
Response at systemic treatment on CT.

Contacts

Public ContactH.W.M. Laarhoven, van

Department of Medical Oncology (452) Radboud University Nijmegen Medical Centre PO Box 9101

h.vanlaarhoven@onco.umcn.nl+31 (0)24 3610353

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)